The goal of the present study was to develop a competitive PCR assay to mea
sure changes in the expression of endothelial nitric oxide synthase (eNOS)
mRNA levels throughout the canine vascular tree. A partial sequence of cani
ne eNOS cDNA (1.86 kb), inducible NOS (1.95 kb), and neuronal NOS (1.16 kb)
was cultured from canine aortic endothelial cells, LPS-treated canine sple
nic vein endothelial cells, and from canine left ventricle, respectively. C
ompetitor eNOS cDNA (eNOS-C) was constructed via recombinant PCR. Thus, wit
h the use of a standard curve competitive PCR with eNOS-C, the amount of eN
OS mRNA in 500 ng of total RNA was greatest in the circumflex > right coron
ary artery > left anterior descending coronary artery > aorta. The isolatio
n of coronary microvessels from the left ventricle was associated with an e
nrichment of endothelial cell markers such as eNOS, von Willebrand factor,
and caveolin-1, an observation supported by the detection of up to 15-fold
higher levels of eNOS mRNA in coronary microvessels relative to the larger
arteries. The ability to quantify changes in eNOS mRNA. levels throughout t
he canine vasculature should provide greater insight into the molecular mec
hanisms of how this gene is regulated in physiological and pathophysiologic
al states.